Insight
tumour-infiltrating lymphocytes
Miguel Lopez de Rodas Gregorio/medicine.yale.edu

Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy

A recent paper by Miguel Lopez de Rodas, Associate Research Scientist in Pathology at Yale Cancer Center, was mentioned by Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, on X

“Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach”

Authors: Miguel Lopez de Rodas, Maria Villalba-Esparza, Miguel Sanmamed, Lieping Chen, David Rimm and Kurt Schalper.

Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy

“Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach.

Biological properties and biomarker potential for ICI therapy.”

More posts featuring Hidehito Horinouchi.

cancer David Rimm Hidehito Horinouchi Kurt Schalper Lieping Chen Maria Villalba-Esparza Miguel Lopez de Rodas Miguel Sanmamed OncoDaily Oncology